Product Information

FONDAPARINUX 2.5 MG/0.5 ML SYR is a generic product labeled by Sandoz Inc., priced at $22.1623 per ML under NDC 00781344395. Its NADAC has been published 138 times since Jan 27, 2021.

FDA first approved this application on May 15, 2018.

FONDAPARINUX 2.5 MG/0.5 ML SYR

Fondaparinux Sodium
$22.1623per ML

Strength

2.5 mg/.5mL

Manufacturer

Sandoz Inc.

NDC

00781344395

Classification

Generic

Dosage Form

INJECTION

Route

SUBCUTANEOUS

Effective Date

8/19/2026

Active Ingredients

FONDAPARINUX SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA206812

FDA Approved

5/15/2018

On Market Since

6/18/2019

Pharmacological Classes

Factor Xa Inhibitor
Factor Xa Inhibitors

Price Statistics

The NADAC for FONDAPARINUX 2.5 MG/0.5 ML SYR has been published 138 times since Jan 27, 2021, and over the history we have for it it has declined 45.1%. The table below summarizes its recorded NADAC range and movement.

Current price$22.1623 per ML
All-time high$40.3736 (Mar 10, 2021)
All-time low$18.9706 (Apr 22, 2026)
52-week high$25.9082
52-week low$18.9706
Median price$24.5572
Average price$25.4543
Largest weekly change-39.2% (May 22, 2024)
Weeks tracked138
Tracking sinceJan 27, 2021

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+12.7%

1Y

-14.5%

3Y

-45.1%

5Y

-45.1%

All

-45.1%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 48% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 48%

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of FONDAPARINUX 2.5 MG/0.5 ML SYR?

The current National Average Drug Acquisition Cost (NADAC) for FONDAPARINUX 2.5 MG/0.5 ML SYR, manufactured by Sandoz Inc., is $22.1623 per ML (NDC 00781344395), effective Nov 18, 2026.

How has the price of FONDAPARINUX 2.5 MG/0.5 ML SYR changed over time?

Over the history we have for it, the NADAC for FONDAPARINUX 2.5 MG/0.5 ML SYR has declined 45.1%. It has been tracked across 138 weekly CMS publications since Jan 27, 2021.

What are the highest and lowest recorded NADAC prices for FONDAPARINUX 2.5 MG/0.5 ML SYR?

Since Jan 27, 2021, the NADAC for FONDAPARINUX 2.5 MG/0.5 ML SYR has ranged from a low of $18.9706 (Apr 22, 2026) to a high of $40.3736 (Mar 10, 2021), with a median of $24.5572 per ML.

Are there cheaper alternatives to FONDAPARINUX 2.5 MG/0.5 ML SYR?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FONDAPARINUX 2.5 MG/0.5 ML SYR, is $11.6100 per ML — about 48% below FONDAPARINUX 2.5 MG/0.5 ML SYR.

Who manufactures FONDAPARINUX 2.5 MG/0.5 ML SYR?

FONDAPARINUX 2.5 MG/0.5 ML SYR (NDC 00781344395) is labeled by Sandoz Inc., and CMS classifies it as a generic product.